Antimicrobial Activity of Dalbavancin against Staphylococcus aureus with Decreased Susceptibility to Glycopeptides, Daptomycin, and/or Linezolid from U.S. Medical Centers. [electronic resource]
Producer: 20190514ISSN:- 1098-6596
- Aminoglycosides -- pharmacology
- Anti-Bacterial Agents -- pharmacology
- Daptomycin -- pharmacology
- Drug Resistance, Multiple, Bacterial -- drug effects
- Hospitals
- Humans
- Linezolid -- pharmacology
- Lipoglycopeptides -- pharmacology
- Microbial Sensitivity Tests
- Staphylococcal Infections -- drug therapy
- Staphylococcus aureus -- drug effects
- Teicoplanin -- analogs & derivatives
- United States -- epidemiology
- Vancomycin -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.